Showing results (1231-1240 of 1,273) with videos related to

Sort By:
Pageof 128
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2024
Tissue nano-transfection of antimicrobial genes drives bacterial biofilm killing in wounds and is potentially mediated by extracellular vesiclesTatiana Z Cuellar-Gaviria, Maria Angelica Rincon-Benavides, Hatice Nur Halipci Topsakal, et al.
Advanced Healthcare Materials|January 11, 2022
Designer Extracellular Vesicles Modulate Pro-Neuronal Cell Responses and Improve Intracranial RetentionLilibeth Ortega-Pineda, Alec Sunyecz, Ana I Salazar-Puerta, et al.
Nature Biotechnology|November 6, 2004
A common open representation of mass spectrometry data and its application to proteomics researchPatrick G A Pedrioli, Jimmy K Eng, Robert Hubley, et al.
The New England Journal of Medicine|March 19, 2019
Antibacterial Envelope to Prevent Cardiac Implantable Device InfectionKhaldoun G Tarakji, Suneet Mittal, Charles Kennergren, et al.
Frontiers in Immunology|November 21, 2022
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancerMathieu J F Crupi, Zaid Taha, Thijs J A Janssen, et al.
Nature Materials|February 17, 2025
Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous systemChang Wang, Yonger Xue, Tamara Markovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2024
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate CancerTanya Dorff, Lisa G Horvath, Karen Autio, et al.
Journal of Pain and Symptom Management|May 20, 2022
ProPACC: Protocol for a Trial of Integrated Specialty Palliative Care for Critically Ill Older AdultsSarah K Andersen, Grace Vincent, Rachel A Butler, et al.
Nature Communications|August 23, 2024
Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapyZaid Taha, Mathieu Joseph François Crupi, Nouf Alluqmani, et al.
NPJ Vaccines|April 2, 2026
Cattle antibodies identify a cross-serotype broadly neutralising foot-and-mouth disease virus epitopeMarie Bonnet-Di Placido, Helen M E Duyvesteyn, Angela W Steyn, et al.
Pageof 128